|
|
Volumn 34, Issue 3, 2002, Pages 926-928
|
|
Clinical small bowel transplantation: Focus on mucosal barrier function
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIBIOTIC AGENT;
ARGININE;
GLUTAMIC ACID;
IMMUNOGLOBULIN;
INTERLEUKIN 2 RECEPTOR;
INTERLEUKIN 2 RECEPTOR ANTIBODY;
OMEGA 3 FATTY ACID;
PROSTAGLANDIN DERIVATIVE;
RAPAMYCIN;
STEROID;
TACROLIMUS;
THYMOCYTE ANTIBODY;
CLINICAL ARTICLE;
CONFERENCE PAPER;
CONTROLLED STUDY;
ENTERIC FEEDING;
FLUORESCENCE ACTIVATED CELL SORTING;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMAN;
HUMAN TISSUE;
IMMUNOSUPPRESSIVE TREATMENT;
INTESTINE MUCOSA;
INTESTINE TRANSPLANTATION;
LACTOBACILLUS;
LEUKOCYTE COUNT;
MULTIPLE ORGAN FAILURE;
NEPHROLITHIASIS;
PERITONITIS;
PRIORITY JOURNAL;
PROCTOCOLECTOMY;
REPERFUSION INJURY;
SHORT BOWEL SYNDROME;
SURGICAL TECHNIQUE;
BIOLOGICAL MARKERS;
BIOPSY;
DRUG THERAPY, COMBINATION;
ENTERAL NUTRITION;
FLUID THERAPY;
GRAFT REJECTION;
HUMANS;
HYALURONIC ACID;
IMMUNOSUPPRESSIVE AGENTS;
INTESTINAL MUCOSA;
INTESTINE, SMALL;
ORGAN PRESERVATION;
SHORT BOWEL SYNDROME;
SURVIVAL RATE;
TIME FACTORS;
TRANSPLANTATION, HOMOLOGOUS;
|
|
EID: 0036258915
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(02)02674-X Document Type: Conference Paper |
|
Times cited : (4)
|
|
References (12)
|
